Glaivy Batsuli

Has grant

Assistant Professor

Stanford University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Glaivy Batsuli is an Assistant Professor at Stanford University, USA. Her research focuses on inherited bleeding disorders, with recent publications addressing topics such as the real-world effectiveness of treatments for hemophilia, assessments of menstrual health in adolescents with sickle cell disease, and the pharmacokinetics of factor X for hereditary deficiency. She is dedicated to improving management and outcomes for patients with bleeding disorders through innovative research and community collaboration.

Recent Grants

Grant: Close

Characterizing the immune response to the C1 domain of factor VIII

Open Date: 2016-07-01

Close Date: 2018-12-01

Grant: Close

Characterizing the immune response to the C1 domain of factor VIII

Open Date: 2015-12-01

Close Date: 2017-11-01

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (8)

Lindsey George

Assistant Professor (Tenure Track)

University of Pennsylvania Perelman School of Medicine

UNITED STATES

University of Michigan

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Glaivy Batsuli

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (13)

Direct Optical Detection of Factor Xa Activity in Minimally Processed Whole Blood

Real‐world effectiveness of eptacog beta in patients with haemophilia and inhibitors: A multi‐institutional case series

Assessment of menstrual health in adolescent and young adults with sickle cell disease

Severe muscle bleeds in children and young adults with hemophilia A on emicizumab prophylaxis: Real‐world retrospective multi‐institutional cohort

The impact of concurrent X chromosome anomalies on diagnosis and bleeding phenotype in children with hemophilia: A single‐institution case series

Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and funding

Removal of single‐site N‐linked glycans on factor VIII alters binding of domain‐specific monoclonal antibodies

A review of the pharmacokinetics, efficacy and safety of high‐purity factor X for the prophylactic treatment of hereditary factor X deficiency

Iron deficiency anemia and bleeding management in pediatric patients with Bernard‐Soulier syndrome and Glanzmann Thrombasthenia: A single‐institution analysis

Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor

Plasma factor IX: The tip of the iceberg?

Emicizumab in tolerized patients with hemophilia A with inhibitors: A single‐institution pediatric cohort assessing inhibitor status

Use of plasma‐derived factor X concentrate in neonates and infants with congenital factor X deficiency

Collaborators (8)

Lindsey George

Guy Young

Shannon Meeks

KIMBERLEY YOUKHANA

Renhao Li

Margaret Ragni

Corinna Schultz

Jordan A. Shavit

Make your next move.